Stromal Cell-Derived Factor-1α Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis

被引:75
作者
Frederick, John R. [1 ]
Fitzpatrick, J. Raymond, III [1 ]
McCormick, Ryan C. [1 ]
Harris, David A. [1 ]
Kim, Ah-Young [1 ]
Muenzer, Jeffrey R. [1 ]
Marotta, Nicole [1 ]
Smith, Maximilian J. [1 ]
Cohen, Jeffrey E. [1 ]
Hiesinger, William [1 ]
Atluri, Pavan [1 ]
Woo, Y. Joseph [1 ]
机构
[1] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA
关键词
angiogenesis; vasculogenesis; endothelial progenitor cells; extracellular matrix; ischemic heart disease; GROWTH-FACTOR; ISCHEMIC CARDIOMYOPATHY; CARDIAC-FUNCTION; TRANSPLANTATION; ANGIOGENESIS; THERAPY; NEOVASCULARIZATION; REVASCULARIZATION; PERFUSION;
D O I
10.1161/CIRCULATIONAHA.109.930404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial ischemia causes cardiomyocyte death, adverse ventricular remodeling, and ventricular dysfunction. Endothelial progenitor cells (EPCs) have been shown to ameliorate this process, particularly when activated with stromal cell-derived factor-1 alpha (SDF), known to be the most potent EPC chemokine. We hypothesized that implantation of a tissue-engineered extracellular matrix (ECM) scaffold seeded with EPCs primed with SDF could induce borderzone neovasculogenesis, prevent adverse geometric remodeling, and preserve ventricular function after myocardial infarction. Methods and Results-Lewis rats (n=82) underwent left anterior descending artery ligation to induce myocardial infarction. EPCs were isolated, characterized, and cultured on a vitronectin/collagen scaffold and primed with SDF to generate the activated EPC matrix (EPCM). EPCM was sutured to the anterolateral left ventricular wall, which included the region of ischemia. Control animals received sutures but no EPCM. Additional groups underwent application of the ECM alone, ECM primed with SDF (ECM+SDF), and ECM seeded with EPCs but not primed with SDF (ECM+SDF). At 4 weeks, borderzone myocardial tissue demonstrated increased levels of vascular endothelial growth factor in the EPCM group. When compared to controls, Vessel density as assessed by immunohistochemical microscopy was significantly increased in the EPCM group (4.1 versus 6.2 vessels/high-powered field; P<0.001), and microvascular perfusion measured by lectin microangiography was enhanced 4-fold (0.7% versus 2.7% vessel volume/section volume; P=0.04). Comparisons to additional groups also showed a significantly improved vasculogenic response in the EPCM group. Ventricular geometry and scar fraction assessed by digital planimetric analysis of sectioned hearts exhibited significantly preserved left ventricular internal diameter (9.7 mm versus 8.6 mm; P=0.005) and decreased infarct scar formation expressed as percent of total section area (16% versus 7%; P=0.002) when compared with all other groups. In addition, EPCM animals showed a significant preservation of function as measured by echocardiography, pressure-volume conductance, and Doppler flow. Conclusions-Extracellular matrix seeded with EPCs primed with SDF induces borderzone neovasculogenesis, attenuates adverse ventricular remodeling, and preserves ventricular function after myocardial infarction. (Circulation. 2010; 122[suppl 1]:S107-S117.)
引用
收藏
页码:S107 / S117
页数:11
相关论文
共 25 条
  • [1] [Anonymous], 2008, WORLD HLTH STAT 2008
  • [2] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [3] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
    Asahara, T
    Masuda, H
    Takahashi, T
    Kalka, C
    Pastore, C
    Silver, M
    Kearne, M
    Magner, M
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 221 - 228
  • [4] Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI)
    Assmus, B
    Schächinger, V
    Teupe, C
    Britten, M
    Lehmann, R
    Döbert, N
    Grünwald, F
    Aicher, A
    Urbich, C
    Martin, H
    Hoelzer, D
    Dimmeler, S
    Zeiher, AM
    [J]. CIRCULATION, 2002, 106 (24) : 3009 - 3017
  • [5] Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy - Invited commentary
    Atluri, P
    Liao, GP
    Panlilio, CM
    Hsu, VM
    Leskowitz, MJ
    Morine, KJ
    Cohen, JE
    Berry, MF
    Suarez, EE
    Murphy, DA
    Lee, WMF
    Gardner, TJ
    Sweeney, HL
    Woo, YJ
    Dormond, O
    Madsen, JC
    [J]. ANNALS OF THORACIC SURGERY, 2006, 81 (05) : 1728 - 1737
  • [6] BROWN L, 2002, HEART LUNG CIRC, V11, P67
  • [7] Tissue engineered endothelial progenitor cell construct promotes neovasculogenesis, enhances perfusion, and improves ventricular function after myocardial infarction
    Frederick, John R.
    Fitzpatrick, J. Raymond
    McCormick, Ryan C.
    Harris, David A.
    Kim, Ah-Young
    Muenzer, Jeffrey R.
    Smith, Maximilian J.
    Cohen, Jeffrey E.
    Atluri, Pavan
    Woo, Y. Joseph
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S91 - S92
  • [8] Frederick JR, 2009, J AM COLL CARDIOL, V53, pA314
  • [9] Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy
    Gee, MS
    Procopio, WN
    Makonnen, S
    Feldman, MD
    Yeilding, NM
    Lee, WMF
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) : 183 - 193
  • [10] Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity
    Ii, M
    Nishimura, H
    Iwakura, A
    Wecker, A
    Eaton, E
    Asahara, T
    Losordo, DW
    [J]. CIRCULATION, 2005, 111 (09) : 1114 - 1120